Rafael Holdings to Report First Quarter Fiscal Year 2019 Results

NEWARK, N.J., Dec. 6, 2018 /PRNewswire/ -- Rafael Holdings, Inc., RFL, has scheduled its report of financial and operational results covering the first quarter of its 2019 fiscal year (the three months ended October 31, 2018) for Monday, December 10, 2018.

www.rafaelholdings.com (PRNewsfoto/Rafael Holdings, Inc.)" alt="Rafael Holdings holds commercial real estate assets and interests in two clinical stage pharmaceutical companies. The pharmaceutical holdings consist of interests in Rafael Pharmaceuticals, Inc. and a majority stake in Lipomedix Pharmaceuticals Ltd., both of which are focused on development and commercialization of drugs in the oncology space. For more information, visit www.rafaelholdings.com (PRNewsfoto/Rafael Holdings, Inc.)">

Rafael Holdings will issue an earnings release and post it on the Rafael Holdings investor relations website (http://rafaelholdings.irpass.com/) at 4:30 PM on December 10^th.  The Company expects to file its quarterly report (Form 10-Q) with the Securities and Exchange Commission shortly thereafter.

About Rafael Holdings, Inc.:
Rafael Holdings holds commercial real estate assets and interests in two clinical stage pharmaceutical companies.  The real estate holdings consist of properties in Newark and Piscataway, New Jersey and Jerusalem, Israel.  The pharmaceutical holdings consist of interests in Rafael Pharmaceuticals, Inc. and a majority stake in Lipomedix Pharmaceuticals Ltd.  Both are focused on development and commercialization of drugs in the oncology space.  For more information, visit www.rafaelholdings.com.

SOURCE Rafael Holdings, Inc.